AA Medical Forms Partnership With Certified Endoscopy Products

AA Medical has completed a “partnership” with Certified Endoscopy Products, a medical device reprocessing company specialized in endoscopic devices. Together, AA Medical and Certified Endoscopy will form a pre-eminent medical device reprocessing company serving the endoscopy, orthopedic, and other surgical device markets.

“We are excited to announce our partnership with Certified Endoscopy and jointly work towards our goal of connecting the world with life-sustaining medical equipment,” AA Medical CEO Matt Nelson said.
 
AA Medical works with physicians in more than 100 countries and has grown into one of the largest aftermarket equipment companies in endoscopy, orthopedics and other specialties. The company partnered with Shore Capital Partners, a private equity firm focused on microcap investing, in April 2022 to build a technology-driven medical equipment platform. The partnership with Certified Endoscopy aligns with AA Medical’s growth strategy and vision.
 
Founded by Michael Cole and John Fuller, Certified Endoscopy provides surgical equipment at affordable prices to customers worldwide. Cole and Fuller are veterans in the medical device industry, with more than 45 years of combined experience. The company serves thousands of customers in over 80 countries.
 
“We look forward to uniting two of the leading companies within surgical device reprocessing. Our joint platform can revolutionize the third-party medical equipment market and ensure physicians have the equipment necessary to provide their patients with the best possible outcomes,” Cole said.

“Our organizations have a lot to learn from each other to drive even faster growth for our companies and better service for our customers,” Fuller added.
 
The relationship between the Certified and AA Medical teams dates back to AA Medical Founder Ron Plantz’s and Fuller’s shared beginnings at Stryker Corp. Before founding Certified Endoscopy, Cole was a leader at AA Medical and worked closely alongside the current AA Medical team.
 
“Certified and AA Medical have competed as peers for several years, and united together, we believe we possess the scale and market knowledge to drive transformational growth for our businesses,” Plantz said. 
 
AA Medical and Shore are partnering to build a strong and diversified medical reprocessing company together through new industry partnerships, business development and further investment in the company’s products and team.
 
“Shore is proud to partner with John, Mike, and the entire Certified Endoscopy family. We have developed a strong relationship with the leadership team over the past year and believe Certified has built an excellent business focused on serving their customers’ unique needs,” said Don Pierce,  a partner at Shore Capital and AA Medical board member.
 
AA Medical has provided sustainable solutions to both the new and resale medical equipment markets since 2012, with a concentration in endoscopic, orthopedic, and other surgical devices. As a critical partner in cost containment, AA Medical helps medical facilities unlock residual value from unneeded equipment while providing reprocessed equipment that otherwise would be prohibitively expensive to purchase new to small, rural, specialty, and international medical facilities. 
 
Certified Endoscopy is a medical device reprocessing company based in Schiller Park, Ill., with a concentration in endoscopy equipment for the visualization, arthroscopic, laparoscopic, and other surgical end markets. 
 
Shore Capital, a Chicago-based private equity firm with offices in Nashville, Tenn., is focused on microcap investments within the healthcare, food and beverage, business services, and real estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles.